T. Declan Walsh, M.D.

Declan Walsh, MSc, FACP, FRCP, became the first Director of the new Palliative Care Program at the Cleveland Clinic Cancer Center in 1987.  In October 1991, the program was designated as a national and international demonstration project by the World Health Organization. He was elected a Fellow of the American College of Physicians in 1988 and a Fellow of the Royal College of Physicians (Edinburgh) in 1998. 

In 1996, an endowed Chair of Palliative Medicine was created at Cleveland Clinic by the HRH Foundation with Dr. Walsh as the first incumbent. He became Chief Executive Officer of Cleveland Clinic Home Care in 2000. He was appointed Division Chairman for Post Acute Medicine in 2003. He was elected to the Cleveland Clinic’s Board of Governors in 2004. Dr. Walsh is a founding member of both the European Association of Palliative Care and the American Academy of Hospice and Palliative Medicine.

His research interests lie in the clinical syndromes common in advanced cancer, and in the clinical pharmacology of symptom control. 

Dr. Walsh is associate editor of the journal Supportive Care in Cancer. He also serves on the editorial boards for The American Journal of Hospice and Palliative Medicine, Palliative Medicine, Journal of Supportive Oncology, and Supportive Cancer Therapy. In 2008, he worked with Elsevier on a textbook for palliative medicine, of which he is the editor.

Cancer pain, symptom control, palliative medicine, hospice care, complications of cancer.

• "Best Doctors in America," 2007
• "Best Doctors in America," 2006
• "Best Doctors in America," 2005
• "Best Doctors in America," 2004
• "Best Doctors in America," 2003
• "Best Doctors in America,"  2002
• Marquis "Who’s Who in America" 55th Edition, 2001

• Ohio Medical Association
• American Society for Clinical Oncology
• American Academy of Hospice and Palliative Medicine
• Multinational Association for Supportive Care in Cancer
• European Association of Palliative Care

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/5/2008, Dr. Walsh has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)